Dear Colleagues,
Many thanks to everyone who has participated in the review of the draft for population PK data standard, sponsored by ISoP's Standards and Best Practices Committee.
We have received lots of great comments and there have been a request to extend the review, as the year-end kept many people quite busy.
Therefore, if you wish to contribute, please do so by 31-Jan-2018 using "Suggesting" mode (top right-hand corner of the Google Docs interface).
https://urldefense.proofpoint.com/v2/url?u=https-3A__docs.google.com_document_d_1MUGiU6U-2D52pw-5FnojPD5lNR9PrTxoEeM3IQFLWeDOM6A_edit-3Fusp-3Dsharing&d=DwMFaQ&c=ZbgFmJjg4pdtrnL2HUJUDw&r=mS8o80zY_amVkf1tPfjwJooaDw3Wi4LREYW3mgf4EPza__UFGeQmeuHQrtl_2pdl&mAX3HQa9qNK0vf9uGUvKi5gl7hK2BsYsog1jykiIX4&s=AzzHiDUEWjSphpVvaJoLtJ4Ydptc-Q42Rce8xnakbkI&e=
We also opened up a document to keep track of your suggestions and address them as we take them into account.
https://docs.google.com/document/d/1yIA6ZSHoY60GqMx3YzMv4bmiMJ36vyFtQ3ABBpT8Xxk/edit?usp=sharing
Thanks very much!
Best regards,
Andrijana
Andrijana Radivojevic, PhD
Associate Director, Pharmacometrics
T +1 862 778-1152
M +1 917 714-1215
andrijana.radivojevic_at_novartis.com<mailto:andrijana.radivojevic_at_novartis.com>
Novartis Pharmaceuticals Corporation
One Health Plaza, 135/108A
East Hanover, NJ 07936-1080
USA